Clinical Trial Update: Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating recombinant human serum albumin in patients with liver cirrhosis and ascites has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Ascites
• Liver Cirrhosis

Drugs mentioned

• Recombinant Human Serum Albumin (recombinant human serum albumin)

Snippet

Sponsor: Protgen Ltd | Conditions: Hepatic Ascites | Phase 1 | Status: COMPLETED